BE801350A - Nouveaux composes spiranniques leur preparation et leur application comme medicaments - Google Patents

Nouveaux composes spiranniques leur preparation et leur application comme medicaments

Info

Publication number
BE801350A
BE801350A BE132645A BE132645A BE801350A BE 801350 A BE801350 A BE 801350A BE 132645 A BE132645 A BE 132645A BE 132645 A BE132645 A BE 132645A BE 801350 A BE801350 A BE 801350A
Authority
BE
Belgium
Prior art keywords
spirannic
compounds
preparation
new
application
Prior art date
Application number
BE132645A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE801350A publication Critical patent/BE801350A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
BE132645A 1973-06-15 1973-06-22 Nouveaux composes spiranniques leur preparation et leur application comme medicaments BE801350A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2330482A DE2330482A1 (de) 1973-06-15 1973-06-15 Neue organische verbindungen und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BE801350A true BE801350A (fr) 1973-12-26

Family

ID=5884082

Family Applications (1)

Application Number Title Priority Date Filing Date
BE132645A BE801350A (fr) 1973-06-15 1973-06-22 Nouveaux composes spiranniques leur preparation et leur application comme medicaments

Country Status (6)

Country Link
JP (1) JPS5019749A (fr)
BE (1) BE801350A (fr)
DE (1) DE2330482A1 (fr)
FR (1) FR2244477A1 (fr)
NL (1) NL7308557A (fr)
SE (1) SE7308238L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517311A (en) * 1981-10-19 1985-05-14 Hoechst-Roussel Pharmaceuticals Inc. 2'-Substituted-spiro[benzofuran-2(3H),1'-cycloalkanes] and their analgesic and anti-depressant compositions
CN105017037B (zh) * 2014-05-03 2018-01-19 复旦大学 6‑取代芳基氨基甲基四氢萘衍生物或其盐类，及其制备方法和用途

Also Published As

Publication number Publication date
NL7308557A (fr) 1974-12-24
DE2330482A1 (de) 1975-01-09
JPS5019749A (fr) 1975-03-01
FR2244477A1 (en) 1975-04-18
SE7308238L (fr) 1974-12-13

Similar Documents

Publication Publication Date Title
FR2283690A1 (fr) Nouveaux composes tetracycliques utiles comme medicaments et leur procede de preparation
BE799332A (fr) Nouveaux derives du benzothiadiazole, leur preparation et leur application comme medicaments
BE783219A (fr) Nouveaux composes heterocycliques, leur preparation et leur applicationcomme medicaments
BE786713A (fr) Nouveaux amino-alcools, leur preparation et leur application comme medicaments
FR2282889A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
FR2303560A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
BE783625A (fr) Nouveaux derives de l'ergolene, leur preparation et leur application comme medicaments
FR2275200A1 (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
BE792078A (fr) Nouveaux derives de l'indazole, leur preparation et leur application comme medicaments
BE790604A (fr) Nouveaux aminoalcanols, leur preparation et leur application comme medicaments
BE787804A (fr) Nouveaux composes spiranniques, leur preparation et leur application comme medicaments
FR2342065A1 (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
BE787235A (fr) Nouveaux derives du thiophene, leur preparation et leur application comme medicaments
BE792079A (fr) Nouveaux composes insatures, leur preparation et leur application commemedicaments
BE825643A (fr) Nouveaux derives du biphenyle, leur preparation et leur application comme medicaments
BE801268A (fr) Nouveaux derives de l'oxindole leur preparation et leur application comme medicaments
BE801350A (fr) Nouveaux composes spiranniques leur preparation et leur application comme medicaments
BE805793A (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
BE785389A (fr) Nouveaux amino-alcools, leur preparation et leur application comme medicaments
BE858887A (fr) Nouveaux perhydro-indolinols, leur preparation et leur application comme medicaments
BE831488A (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
BE819946A (fr) Nouveaux carbamates et leur utilisation comme medicaments
BE834756A (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
BE787059A (fr) Nouveaux derives du thiazole, leur preparation et leur application comme medicaments
BE843039A (fr) Nouveaux derives de benzo-cyclochepta-thiophene, leur preparation et leur application comme medicaments